Skip to main content
ALLO
NASDAQ Life Sciences

TPG Funds Exit Allogene Entirely, Selling 18.7M Shares at $1.55

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.619
Mkt Cap
$552.785M
52W Low
$1.04
52W High
$4.46
52W Position info
56% above low
Off High info
64% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

ALLO sits 56% above its 52-week low of $1.04.

Summary

TPG Funds sold their entire 18.7M share position in Allogene at $1.55 per share, exiting the stock completely after holding since 2018.


Key Events · Ownership and Investor Activity · ALLO

  • TPG Funds Complete Exit

    TPG Funds sold 18,716,306 shares at $1.55 per share on September 28, 2026, eliminating their entire position in Allogene.

  • Sale Proceeds

    The block sale generated approximately $29.0M in proceeds (18,716,306 shares × $1.55).

  • Ownership Falls Below 5%

    As a result of the sale, the Reporting Persons no longer beneficially own any shares and ceased to be 5% beneficial owners.

  • Long-Term Holder Exits

    TPG had held Allogene shares since the company's October 2018 IPO, making this a complete exit by a founding institutional investor.


Analysis · ALLO · Life Sciences

TPG Funds sold their entire remaining stake of 18,716,306 shares at $1.55 per share on September 28, 2026, and no longer hold any Allogene common stock. This is a complete exit by a major institutional investor that had been a shareholder since the company's 2018 IPO. The sale price of $1.55 is below today's $1.62, and the block represents a significant overhang removal. For a company with a $553M market cap, a $29M block sale by a long-term holder signals reduced institutional conviction, though it also removes a large overhang that may have been weighing on the stock.

How filings like this one have moved

In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ALLO was trading at $1.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $552.8M. The 52-week trading range was $1.04 to $4.46. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ALLO - Latest Insights

ALLO
Aug 12, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
7
ALLO
Aug 12, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
9
ALLO
Jul 29, 2026, 8:36 AM EDT
Source: Reuters
Importance Score:
8
ALLO
Jun 22, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
ALLO
Jun 22, 2026, 4:03 PM EDT
Filing Type: 424B5
Importance Score:
7